Journals / Turkish Journal of Medical Sciences / 2010 / Cilt: 40 - Sayı: 1

Kan örneklerinden izole edilen Candida kökenlerinin antifungal duyarlılıklarının karşılaştırmalı değerlendirmesi: Üçüncü basamak bir hastane’nin çalışma sonuçları (Bursa-Türkiye)

Comparative evaluation of the antifungal susceptibility of andida isolates from blood specimens: Results of a study in a tertiary care hospital in Bursa, Turkey

Pages
141–149
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The MICs obtained with each of the methods were read after 24 h and 48 h of incubation.Results: Overall agreement rates within ±1 dilution between the 2 methods were 86.7% (24 h) and 94.1% (48 h) for amphotericin B, and 85.5% (24 h) and 73.3% (48 h) for fluconazole.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Aim: Antifungal susceptibility testing may be an important aid in the treatment of patients with life threatening yeast infections.
📊
Key Findings & Data:Materials and methods: Susceptibility to antifungal agents was investigated using the Etest (AB Biodisk, Solna, Sweden) and the reference broth macrodilution susceptibility test (CLSI M27-A2).
💡
Conclusion & Impact:The MICs obtained with each of the methods were read after 24 h and 48 h of incubation.Results: Overall agreement rates within ±1 dilution between the 2 methods were 86.7% (24 h) and 94.1% (48 h) for amphotericin B, and 85.5% (24 h) and 73.3% (48 h) for fluconazole.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Aim: Antifungal susceptibility testing may be an important aid in the treatment of patients with life threatening yeast infections. The aim of this study was to determine the susceptibility of Candida isolates obtained from clinical specimens to the antifungal agents amphotericin B and fluconazole, which are frequently used in our clinical practice. Materials and methods: Susceptibility to antifungal agents was investigated using the Etest (AB Biodisk, Solna, Sweden) and the reference broth macrodilution susceptibility test (CLSI M27-A2). The MICs obtained with each of the methods were read after 24 h and 48 h of incubation.Results: Overall agreement rates within ±1 dilution between the 2 methods were 86.7% (24 h) and 94.1% (48 h) for amphotericin B, and 85.5% (24 h) and 73.3% (48 h) for fluconazole. All C. albicans, C. pelliculosa, C. glabrata, and C. kefyr isolates were inhibited by ≤1 μg mL−1 of amphotericin B, and fluconazole resistance was not observed in C. albicans or C. tropicalis isolates according to the 2 methods. Conclusion: According to the results of this study, decreased susceptibility to fluconazole and amphotericin B was most prominent in C. parapsilosis, C. krusei, and C. glabrata isolates.

Özet

Amaç: Antifungal duyarlılık testleri, yaşamı tehdit eden maya mantarı enfeksiyonu olan hastaların tedavisinde büyük önem taşımaktadır. Bu çalışmanın amacı klinik örneklerden soyutlanan Candida kökenlerinin pratik uygulamada sıklıkla kullanılan antifungal ilaçlar olan amfoterisin B ve flukonazole duyarlılıklarının belirlenmesidir.Yöntem ve gereç: Antifungal ilaçlara duyarlılık, Etest (AB Biodisk, Solna, İsveç) ve referans broth makrodilüsyon duyarlılık testi (CLSI M27-A2) ile araştırıldı. MİK değerleri, her iki yöntem ile 24 ve 48 saatlik inkübasyonun sonunda değerlendirildi. Bulgular: İki yöntem arasında (±) 1 dilüsyon içinde uyum oranları, amfoterisin B için % 86,7 (24 saat) ve % 94,1 (48 saat), flukonazol için % 85,5 (24 saat) ve % 73,3 (48 saat) idi. C. albicans, C. pelliculosa, C. glabrata ve C. kefyr kökenlerinin tümü, ≤1 μg mL−1 konsantrasyonda amfoterisin B ile inhibe oldu ve C. albicans ya da C. tropicalis kökenlerinde her iki yöntem ile flukonazole direnç saptanmadı.Sonuç: Bu çalışmada, flukonazol ve amfoterisin B’ye duyarlılığın azalması, en belirgin olarak C. parapsilosis, C. krusei ve C. glabrata kökenlerinde görüldü.

🔖

Cite This Article

AKÇAĞLAR, S., GÖRAL, G., EVCİ, C., ENER, B. (2022). Kan örneklerinden izole edilen Candida kökenlerinin antifungal duyarlılıklarının karşılaştırmalı değerlendirmesi: Üçüncü basamak bir hastane’nin çalışma sonuçları (Bursa-Türkiye). Turkish Journal of Medical Sciences, Cilt: 40 - Sayı: 1, 141–149. https://ajindex.com/articles/611482

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (10)

  1. Rex JH, Pfaller MA, Walsh TJ, Chaturvedi V, Espinel-Ingrof A, Ghannoum MA et al. Antifungal susceptibility testing: practical aspects and current challenges. Clin Microbiol Rev 2001; 14: 643-58
  2. Sewell DL, Pfaller MA, Barry AL. Comparison of broth macrodilution, broth microdilution, and Etest antifungal susceptibility tests for luconazole. J Clin Microbiol 1994; 32: 2099-102
  3. Wanger A, Mills K, Nelson PW, Rex JH. Comparison of Etest and National Committee for Clinical Laboratory Standards broth macrodilution method for antifungal susceptibility testing: enhanced ability to detect amphotericin B-resistant Candida isolates. Antimicrob Agents Chemother 1995; 39: 2520-2
  4. Espinel-Ingrof A, Pfaller M, Erwin ME, Jones RN. Interlaboratory evaluation of Etest method for testing antifungal susceptibilities of pathogenic yeasts to ive antifungal agents by using Casitone agar and solidiied RPMI 1640 medium with 2% glucose. J Clin Microbiol 1996; 34: 848-52
  5. Chryssanthou E. Trends in antifungal susceptibility among Swedish Candida species bloodstream isolates from 1994 to 1998: comparison of the Etest and the Sensititre YeastOne Colorimetric Antifungal Panel with the NCCLS M27-A reference method. J Clin Microbiol 2001; 39: 4181-3
  6. Pfaller MA, Diekema DJ, Messer SA, Boyken L, Hollis RJ. Activities of luconazole and voriconazole against 1586 recent clinical isolates of Candida species determined by Broth microdilution, disk difusion, and Etest methods: report from the ARTEMIS Global Antifungal Susceptibility Program, 2001. J Clin Microbiol 2003; 41: 1440-6
  7. Maxwell MJ, Messer SA, Hollis RJ, Boyken L, Tendolkar S, Diekema DJ et al. Evaluation of Etest method for determining luconazole and voriconazole MICs for 279 clinical isolates of Candida species infrequently isolated from blood. J Clin Microbiol 2003; 41: 1087-90
  8. National Committee for Clinical Laboratory Standards. Reference method for broth dilution antifungal susceptibility testing of yeasts; approved standard. Second edition, Document M27-A2. National Committee for Clinical Laboratory Standards, Wayne, PA. 2002
  9. AB BIODISK. E test technical guide 4: antifungal susceptibility of yeast. 2007. AB BIODISK, Solna Sweden
  10. St-Germain G, Laverdiere M, Pelletier R, Bourgault AM, Libman M, Lemieux C et al. Prevalence and antifungal susceptibility of 442 Candida isolates from blood and other normally sterile sites: results of a 2-year (1996 to 1998) multicenter surveillance study in Quebec, C